A detailed history of Northwest Financial Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Northwest Financial Advisors holds 3,195 shares of ABBV stock, worth $569,956. This represents 0.5% of its overall portfolio holdings.

Number of Shares
3,195
Previous 3,558 10.2%
Holding current value
$569,956
Previous $610 Million 3.38%
% of portfolio
0.5%
Previous 0.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $59,473 - $72,356
-363 Reduced 10.2%
3,195 $631 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $4,334 - $5,061
28 Added 0.79%
3,558 $610 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $62,329 - $71,019
390 Added 12.42%
3,530 $643 Million
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $432,064 - $486,605
3,140 New
3,140 $487 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northwest Financial Advisors Portfolio

Follow Northwest Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Financial Advisors with notifications on news.